Ironwood Pharmaceuticals (FRA:I76) Institutional Ownership : 60.29% (As of Jun. 10, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Ironwood Pharmaceuticals Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Ironwood Pharmaceuticals's institutional ownership is 60.29%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Ironwood Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Ironwood Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 51.41%.

Ironwood Pharmaceuticals Institutional Ownership Historical Data

The historical data trend for Ironwood Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ironwood Pharmaceuticals Institutional Ownership Chart

Ironwood Pharmaceuticals Historical Data

The historical data trend for Ironwood Pharmaceuticals can be seen below:

	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Institutional Ownership	61.89	59.84	57.25	57.41	57.62	56.49	55.96	60.80	60.01	60.29

Ironwood Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Ironwood Pharmaceuticals (FRA:I76) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ironwood Pharmaceuticals Inc (FRA:I76) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

IRWD:USA

Address

100 Summer Street, Suite 2300, Boston, MA, USA, 02110

Website

https://www.ironwoodpharma.com

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Ironwood Pharmaceuticals (FRA:I76) Headlines

No Headlines